Approximately 980,000 tablets of a prescription medicine to treat high blood pressure have been ordered removed from pharmacy shelves, with a full recall to be completed by early August after being found to contain an insufficient amount of a key ingredient, the Food and Drug Administration (FDA) announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan files WTO complaint over Canadian steel tariffs
12/19/2025 05:52 PM - Culture
Irish literature exhibition traces shared colonial legacies with Taiwan
12/19/2025 04:54 PM - Business
U.S. dollar closes higher on Taipei forex market
12/19/2025 04:19 PM - Culture
South Korean girl group Kara to headline Taipei's New Year countdown
12/19/2025 04:11 PM - Politics
KMT, TPP vow to impeach President Lai
12/19/2025 03:22 PM